{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2002"],"condition":["Lung Cancer","Esophageal Neoplasms","Colorectal Cancer","Gastric Cancer","Esophageal Cancer","Colorectal Neoplasms","Anal Cancer","Stomach Neoplasms","Anus Neoplasms"],"disease":["Lung Cancer","Esophageal Neoplasms","Colorectal Cancer","Gastric Cancer","Esophageal Cancer","Colorectal Neoplasms","Anal Cancer","Stomach Neoplasms","Anus Neoplasms"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2042174"],"location":["United States"],"study_start_month":["11"],"keyword":["Survey","Questionnaire","Cytokines","Chemoradiation Therapy"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients","description":"Primary Objectives:\n* To determine the feasibility of a study that would describe changes of certain circulating inflammatory cytokines (interleukin-1, 6, 8, 10, 12, and tumor necrosis factor-alpha [TNF] and symptoms related to chemoradiation therapy (pre-therapy, during therapy and up to 3 months post-therapy) among patients with lung, esophageal, gastric, colorectal and anal cancer.\n* To determine the feasibility of studying neurocognitive function in patients with non-small cell lung cancer (NSCLC) at presentation and during chemoradiation therapy to determine the prevalence, severity, and pattern of cognitive symptoms.","dates":{"creation":"2002-11-15"},"accession":"2042174","cross_references":{"ClinicalTrials___gov":["NCT00502502"]}}